EXPAREL® (Long-Acting Liposomal Bupivacaine) Use for Popliteal Nerve Block in Postoperative Pain Control after Ankle Fracture Fixation

EXPAREL® has been used successfully to prolong postoperative pain control when applied as a wound infiltrate. EXPAREL® has not yet been approved for use in regional anesthesia to prolong postoperative pain control. We conducted a clinical case series of 4 patients using EXPAREL® for sciatic blocks v...

Full description

Saved in:
Bibliographic Details
Main Authors: Patrick Discepola, Mohamed Bouhara, Minho Kwon, Bilal A. Siddiqui, Trevor A. Whitwell, Swetha Y. Sanghvi, Keith D. Cook, Ross E. Moore, Anna Korban, Jean D. Eloy
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Pain Research and Management
Online Access:http://dx.doi.org/10.1155/2020/5982567
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567960879759360
author Patrick Discepola
Mohamed Bouhara
Minho Kwon
Bilal A. Siddiqui
Trevor A. Whitwell
Swetha Y. Sanghvi
Keith D. Cook
Ross E. Moore
Anna Korban
Jean D. Eloy
author_facet Patrick Discepola
Mohamed Bouhara
Minho Kwon
Bilal A. Siddiqui
Trevor A. Whitwell
Swetha Y. Sanghvi
Keith D. Cook
Ross E. Moore
Anna Korban
Jean D. Eloy
author_sort Patrick Discepola
collection DOAJ
description EXPAREL® has been used successfully to prolong postoperative pain control when applied as a wound infiltrate. EXPAREL® has not yet been approved for use in regional anesthesia to prolong postoperative pain control. We conducted a clinical case series of 4 patients using EXPAREL® for sciatic blocks via the popliteal fossa approach. Our results suggested that there is a large degree of variability in response to the medication. These inconsistent results and the possibility of bimodal kinetics creating analgesic gaps as seen in two of our patients indicate that more studies with larger sample size are needed to better characterize these phenomena and determine if more consistent results can be obtained in a future clinical trial.
format Article
id doaj-art-c050e79e682a4ce6aa7801e399256494
institution Kabale University
issn 1203-6765
1918-1523
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Pain Research and Management
spelling doaj-art-c050e79e682a4ce6aa7801e3992564942025-02-03T01:00:09ZengWileyPain Research and Management1203-67651918-15232020-01-01202010.1155/2020/59825675982567EXPAREL® (Long-Acting Liposomal Bupivacaine) Use for Popliteal Nerve Block in Postoperative Pain Control after Ankle Fracture FixationPatrick Discepola0Mohamed Bouhara1Minho Kwon2Bilal A. Siddiqui3Trevor A. Whitwell4Swetha Y. Sanghvi5Keith D. Cook6Ross E. Moore7Anna Korban8Jean D. Eloy9Anesthesiology, Rutgers New Jersey Medical School, Newark, NJ, USAAnesthesiology, Rutgers New Jersey Medical School, Newark, NJ, USAAnesthesiology, Rutgers New Jersey Medical School, Newark, NJ, USAAnesthesiology, Rutgers New Jersey Medical School, Newark, NJ, USAAnesthesiology, Rutgers New Jersey Medical School, Newark, NJ, USAAnesthesiology, Rutgers New Jersey Medical School, Newark, NJ, USAPodiatry, University Hospital, Newark, NJ, USAAnesthesiology, Rutgers New Jersey Medical School, Newark, NJ, USAAnesthesiology, Rutgers New Jersey Medical School, Newark, NJ, USAAnesthesiology, Rutgers New Jersey Medical School, Newark, NJ, USAEXPAREL® has been used successfully to prolong postoperative pain control when applied as a wound infiltrate. EXPAREL® has not yet been approved for use in regional anesthesia to prolong postoperative pain control. We conducted a clinical case series of 4 patients using EXPAREL® for sciatic blocks via the popliteal fossa approach. Our results suggested that there is a large degree of variability in response to the medication. These inconsistent results and the possibility of bimodal kinetics creating analgesic gaps as seen in two of our patients indicate that more studies with larger sample size are needed to better characterize these phenomena and determine if more consistent results can be obtained in a future clinical trial.http://dx.doi.org/10.1155/2020/5982567
spellingShingle Patrick Discepola
Mohamed Bouhara
Minho Kwon
Bilal A. Siddiqui
Trevor A. Whitwell
Swetha Y. Sanghvi
Keith D. Cook
Ross E. Moore
Anna Korban
Jean D. Eloy
EXPAREL® (Long-Acting Liposomal Bupivacaine) Use for Popliteal Nerve Block in Postoperative Pain Control after Ankle Fracture Fixation
Pain Research and Management
title EXPAREL® (Long-Acting Liposomal Bupivacaine) Use for Popliteal Nerve Block in Postoperative Pain Control after Ankle Fracture Fixation
title_full EXPAREL® (Long-Acting Liposomal Bupivacaine) Use for Popliteal Nerve Block in Postoperative Pain Control after Ankle Fracture Fixation
title_fullStr EXPAREL® (Long-Acting Liposomal Bupivacaine) Use for Popliteal Nerve Block in Postoperative Pain Control after Ankle Fracture Fixation
title_full_unstemmed EXPAREL® (Long-Acting Liposomal Bupivacaine) Use for Popliteal Nerve Block in Postoperative Pain Control after Ankle Fracture Fixation
title_short EXPAREL® (Long-Acting Liposomal Bupivacaine) Use for Popliteal Nerve Block in Postoperative Pain Control after Ankle Fracture Fixation
title_sort exparel r long acting liposomal bupivacaine use for popliteal nerve block in postoperative pain control after ankle fracture fixation
url http://dx.doi.org/10.1155/2020/5982567
work_keys_str_mv AT patrickdiscepola exparellongactingliposomalbupivacaineuseforpoplitealnerveblockinpostoperativepaincontrolafteranklefracturefixation
AT mohamedbouhara exparellongactingliposomalbupivacaineuseforpoplitealnerveblockinpostoperativepaincontrolafteranklefracturefixation
AT minhokwon exparellongactingliposomalbupivacaineuseforpoplitealnerveblockinpostoperativepaincontrolafteranklefracturefixation
AT bilalasiddiqui exparellongactingliposomalbupivacaineuseforpoplitealnerveblockinpostoperativepaincontrolafteranklefracturefixation
AT trevorawhitwell exparellongactingliposomalbupivacaineuseforpoplitealnerveblockinpostoperativepaincontrolafteranklefracturefixation
AT swethaysanghvi exparellongactingliposomalbupivacaineuseforpoplitealnerveblockinpostoperativepaincontrolafteranklefracturefixation
AT keithdcook exparellongactingliposomalbupivacaineuseforpoplitealnerveblockinpostoperativepaincontrolafteranklefracturefixation
AT rossemoore exparellongactingliposomalbupivacaineuseforpoplitealnerveblockinpostoperativepaincontrolafteranklefracturefixation
AT annakorban exparellongactingliposomalbupivacaineuseforpoplitealnerveblockinpostoperativepaincontrolafteranklefracturefixation
AT jeandeloy exparellongactingliposomalbupivacaineuseforpoplitealnerveblockinpostoperativepaincontrolafteranklefracturefixation